We passed, Senator Portman and I worked on a legislation called the FENTANYL Results Act, to try and give the State Depa...
I certainly agree, and I hope we will continue to stay focused on other areas where--on individuals where sanctions can ...
Despite the Biden-Harris Administration's prioritization of the repeal of the Global Gag Rule shortly after taking offic...
I share Senator Graham's sentiments about not limiting where we invest to just those countries that are designated by th...
I think it should include, not just national security issues, but also economic and democracy support for what is happen...
I hope that that is a review that also considers the implication on Afghan women and girls.
I think we still need further Government action on that, to make sure that everybody has those out-of-pocket expenses ca...
I am arguing that we should fully fund that program at its authorized level.
I share the concerns that both the Chairman and Senator Risch have expressed not only about the SBDCs but about the dist...
By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve...
The FDA maintains a list of essential medications and medical devices that is intended to inform which supply chains are...
This manufacturing monopoly is one of the root causes of the drug shortage, and relying on China for active ingredients ...
Thank you very much, Mr. Chair and Ranking Member Paul, for holding this hearing.
I also think it is really essential that the FDA and the United States government use this data too.
I also want to say how pleased I am to see the robust funding for the western Balkans in the President's budget.
I think she is courageous and inspiring and they need our help.
I certainly think there is a lot of interest on the part of the members of this committee in doing that.
I wanted to drill down on a bill that Senator Braun and I worked on that was signed into law.
